What a week it was for cholesterol! It was Lipidemia Rollercoaster - here's a summary. First, the kerfuffle with Vytorin. As you have probably heard, Merck and Schering-Plough have been roundly …
Continue Reading about Cholesterol – good, bad, and indifferent →